Table 2.

Table displaying the %ID/g uptake (mean ± SEM) of [¹⁸F]FLT in glioma tissue and contralateral normal brain issue at each of the days post implantation studied

[18F]FDG	Sunitinib treated (%ID/g)		Vehicle treated (%ID/g)
Days post-inoculation	Glioma	Normal brain	Glioma	Normal brain
6	0.06 ± 0.003	0.06 ± 0.003	0.06 ± 0.01	0.05 ± 0.01
9	0.08 ± 0.012	0.06 ± 0.012	0.06 ± 0.00	0.05 ± 0.01
13	0.06 ± 0.011	0.05 ± 0.003	0.11 ± 0.01	0.03 ± 0.01
16	0.06 ± 0.009	0.05 ± 0.007	0.21 ± 0.07	0.05 ± 0.01
20	0.13 ± 0.020	0.05 ± 0.001	0.32 ± 0.06	0.06 ± 0.02
22	0.19 ± 0.019	0.05 ± 0.011	0.48 ± 0.04	0.08 ± 0.01